Cardiovascular Adverse Events Associated With Second-Generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Cardiovascular Adverse Events Associated With Second-Generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-Analysis

Published:2023-12 Issue: Volume: Page:
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Proskuriakova Ekaterina,Shrestha Dhan Bahadur^ORCID,Jasaraj Ranjit,Reddy Vijay Ketan,Shtembari Jurgen,Raut Anuradha,Gaire Suman,Khosla Paramjeet,Kadariya Dinesh

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Editorial: BCR Signaling and B Cell Activation;Liu;Front Immunol,2020

2. How I manage ibrutinib-refractory chronic lymphocytic leukemia;Woyach;Blood,2017

3. Taking IMBRUVICA® (ibrutinib). Pharmacyclics. Accessed September 18, 2023. https://www.imbruvica.com/taking-imbruvica?utm_source=google&utm_medium=cpc&utm_campaign=GO-USA-ENG-PS-Imbruvica-BC-PH-RN-DTC_Core&utm_content=Package+Insert&utm_term=imbruvica+package+insert&gclid=Cj0KCQjwx5qoBhDyARIsAPbMagCaiunEBcWuxylE6L2KlW1_mVuKDqScRtVUe24zH8Nw13htCclP8agaAu28EALw_wcB&gclsrc=aw.ds.

4. Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advances;Wen;Leukemia,2020

5. Ibrutinib combinations in CLL therapy: scientific rationale and clinical results;Timofeeva;Blood Cancer J,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Adverse Events Associated With Second-Generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-Analysis;Clinical Therapeutics;2023-12